GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease

Huiqin Li,Xiang Cao,Xinya Gu,Mengqi Dong,Lili Huang,Chenglu Mao,Shengnan Xia,Haiyan Yang,Xinyu Bao,Yongbo Yang,Yun Xu
DOI: https://doi.org/10.1007/s12264-023-01158-y
IF: 5.271
2024-01-01
Neuroscience Bulletin
Abstract:Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with the development of a network of abnormal vessels. Immune inflammation is associated with the occurrence and development of MMD. However, the mechanisms underlying the formation of the abnormal vascular network remain unclear. Twenty-eight patients with MMD, 26 ischemic stroke patients, and 26 unrelated healthy volunteers were enrolled in this study The data showed that the levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) were higher in MMD patients than in healthy controls ( P <0.01), and GM-CSF was mainly from Th1 and Th17 cells in MMD. We found that increased GM-CSF drove monocytes to secrete a series of cytokines associated with angiogenesis, inflammation, and chemotaxis. In summary, our findings demonstrate for the first time the important involvement of GM-CSF in MMD and that GM-CSF is an important factor in the formation of abnormal vascular networks in MMD.
What problem does this paper attempt to address?